1-4 of 4
Elena Mariggiò, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bosutinib in the Real-Life Treatment of Chronic Phase Chronic Myeloid Leukemia (CML) Patients Aged > 65 Years Resistant/Intolerant to Frontline Tyrosine-Kynase Inhibitors

Roberto Latagliata, Imma Attolico, MD, Malgorzata Monika Trawinska, MD, Isabella Capodanno, MD, Mario Annunziata, MD, Chiara Elena, MD, Luigiana Luciano, Monica Crugnola, MD, Micaela Bergamaschi, MD, Massimiliano Bonifacio, MD, Claudia Baratè, Endri Mauro, MD, Gianni Binotto, MD, Nicola Sgherza, MD, Chiara Aguzzi, MD, Barbara Monteleone, MD, Federica Sorà, MD, Giovanni Caocci, MD, Debora Luzi, Elena Mariggiò, MD, Luigi Scaffidi, MD, Daniele Cattaneo, MD, Antonella Gozzini, MD, Ambra Di veroli, Sara Galimberti, MD PhD, Alessandra Iurlo, MD PhD, Massimo Breccia, MD, Giorgina Specchia, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1649.
https://doi.org/10.1182/blood-2019-127029
Published: 2019
Journal Articles

Frontline Treatment with Dasatinib in Very Elderly Patients (> 75 Years) with Chronic Myeloid Leukemia: Is It Feasible?

Roberto Latagliata, Fabio Stagno, Mario Annunziata, Malgorzata Monika Trawinska, MD, Alessandra Iurlo, Nicola Sgherza, MD, Carmen Fava, Antonella Gozzini, MD, Luigiana Luciano, Massimiliano Bonifacio, Federica Sorà, MD, Sabrina Crescenzi Leonetti, MD, Monica Crugnola, MD, Gabriele Gugliotta, MD PhD, Sara Galimberti, Nicola Orofino, MD, Elena Mariggiò, MD, Costanzo Feo, MD, Mario Tiribelli, Endri Mauro, MD, Antonella Russo Rossi, MD, Attilio Guarini, MD, Elisabetta Abruzzese, MD, Paolo Vigneri, MD PhD, Gianantonio Rosti, Massimo Breccia, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5438.
https://doi.org/10.1182/blood-2018-99-119936
Published: 2018
Journal Articles

Clinical and Prognostic Features of Essential Thrombocythemia: Comparison of Who 2001 Versus Who 2008/2016 Criteria in a Large Single Center Cohort

Sofia Chiatamone Ricci, MD, Maria Antonietta Arleo, MD, Stefania Trasarti, MD, Cristina Santoro, MD PhD, Massimo Breccia, MD, Luisa Bizzoni, MD, Ida Carmosino, Marco Mancini, Erminia Baldacci, MD, Matteo Molica, MD, Daniela De Benedittis, MD, Giulia Ciotti, MD, Elena Mariggiò, MD, Sara Mohamed, MD, Maria Lucia De Luca, MD, Giacinta Pistilli, MD, Annalisa Mancuso, MD, Chiara Lisi, MD, Daniela Diverio, Marco Vignetti, MD, Robin Foà, MD, Roberto Latagliata, Antonietta Ferretti, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5464.
https://doi.org/10.1182/blood-2018-99-117905
Published: 2018
Journal Articles

Five Years after Frontline Tyrosine-Kinase Inhibitor (TKI) Treatment Initiation for Chronic Myeloid Leukemia: What Does It Happen in a Real-Life Setting?

Daniela De Benedittis, MD, Massimo Breccia, MD, Ida Carmosino, Elena Mariggiò, MD, Matteo Molica, MD, Sara Mohamed, MD, Fulvio Massaro, MD, Maria Lucia De Luca, MD, Emilia Scalzulli, MD, Chiara Lisi, MD, Mauro Passucci, MD, Gioia Colafigli, MD, Maria Giovanna Loglisci, MD, Daniela Diverio, Marco Mancini, Robin Foà, MD, Roberto Latagliata
Journal: Blood
Blood (2018) 132 (Supplement 1): 1746.
https://doi.org/10.1182/blood-2018-99-117272
Published: 2018